跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Doxel - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Doxel
Approved
STANDARD
Doxel
Sichuan Huiyu Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5a35410f32baacab
Company
Sichuan Huiyu Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
5a35410f32baacab
Drug Approval Philippines Name
Doxel
Product Name
Doxel
Registration Number
DR-XY46691
Brand Name
Doxel
Generic Name
Docetaxel
Dosage Form
Concentrate Solution For I.V. Infusion
Dosage Strength
20 mg/mL
Manufacturer
Sichuan Huiyu Pharmaceutical Co., Ltd.
Importer
Oncolife Corporation
Distributor
Oncolife Corporation
Company Detail Path
/organization/sichuan-huiyu-pharmaceutical-co-ltd
Issuance Date
29 June 2024
Expiry Date
16 September 2029
Pharmacologic Category
Antineoplastic Agent
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5a35410f32baacab
Type
Standard
Back to Philippines FDA Approvals